Skip to main content
logo
Hepion Pharmaceuticals, Inc. (HEPA)
OTCMKTS · Delayed Price · Currency is USD
0.0652
+0.0117 (21.87%)
At close: Jul 27, 2026

Hepion Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
213142387
Market Cap Growth
184.02%-78.69%-76.72%-38.61%-73.66%23.90%
Enterprise Value
106-3-34-10
Last Close Price
0.070.0623.50162.00300.301140.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.020.26-1.761.930.460.93
P/TBV Ratio
11.750.72-2.520.511.01

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.02-1.560.030.000.00
Net Debt / Equity Ratio
-1.40-0.66-1.34-2.00-1.03-0.98
Net Debt / EBITDA Ratio
-0.48-0.130.321.173.00
Net Debt / FCF Ratio
1.650.54-0.140.361.462.90
Quick Ratio
3.546.110.132.806.4911.13
Current Ratio
3.6810.250.513.317.1611.88
Return on Equity (ROE)
-103.70%-2058.63%-487.03%-171.26%-59.08%-49.02%
Return on Assets (ROA)
-45.42%-100.37%-122.71%-72.21%-33.29%-24.97%
Return on Capital Employed (ROCE)
-166.40%-135.70%1264.40%-353.50%-83.30%-31.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-157.10%-1187.27%-403.30%-348.13%-184.35%-37.66%
FCF Yield
-82.98%-469.22%-556.88%-291.04%-152.80%-36.08%
Buyback Yield / Dilution
-1338.60%-7556.50%-54.75%-4.18%-8.45%-